In the 1970s, an unknown virus was suspected for documented cases of transfusion-
associated hepatitis, a phenomenon called non-A, non-B hepatitis. In 1989, the infectious …

In the early 1900s, numerous seminal publications reported that high rates of cancer
occurred in certain occupations. During this period, work with infectious agents produced …

Hepatocellular carcinoma (HCC) is the commonest primary malignant cancer of the liver in
the world. Given that the burden of chronic liver disease is expected to rise owing to …

Background and Methods To detect potentially curable cases of hepatocellular carcinoma,
outpatients with chronic hepatitis or compensated liver cirrhosis who were seen at the …

Hepatocellular carcinoma (HCC) is the fifth most common neoplasm in the world, and the
third most common cause of cancer‐related death. It affects mainly patients with cirrhosis of …

The management of hepatocellular carcinoma (HCC) has substantially changed in the past
few decades. Improvements in patient stratification (for example, using the Barcelona Clinic …

Hepatocellular carcinoma (HCC) is increasing in incidence in many countries, and is the
most common cause of death in patients with cirrhosis. With regular surveillance, small early …

Hepatitis C has emerged in recent years as the most common basis for liver disease in the
United States, having infected an estimated 3.9 million people in this country and an …

To clarify the relationship between hepatitis C virus infection and the development of
hepatocellular carcinoma as sequelae of non‐A, non‐B posttransfusion hepatitis, 231 …

The aim of the study was to assess whether co‐infection by hepatitis‐B virus (HBV) and
hepatitis‐C virus (HCV) is associated with a higher risk of developing hepatocellular …